Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Quanterix Corp (NQ: QTRX ) 15.56 +0.29 (+1.90%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 257,549 Open 15.62 Bid (Size) 14.93 (1) Ask (Size) 18.18 (1) Prev. Close 15.27 Today's Range 15.34 - 15.92 52wk Range 11.82 - 29.70 Shares Outstanding 38,063,618 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Quanterix to Participate at the Scotiabank Healthcare 1x1 Day June 17, 2024 From Quanterix Corporation Via Business Wire Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference June 05, 2024 From Quanterix Corporation Via Business Wire Performance YTD -42.69% -42.69% 1 Month +19.69% +19.69% 3 Month -0.13% -0.13% 6 Month -34.12% -34.12% 1 Year -33.33% -33.33% More News Read More Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024 May 22, 2024 From Quanterix Corporation Via Business Wire Quanterix Corp. (NASDAQ: QTRX) Highlighted for Surprising Price Action March 01, 2024 Via Investor Brand Network Earnings Scheduled For February 29, 2024 February 29, 2024 Via Benzinga QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 Via InvestorPlace Quanterix Releases Financial Results for the First Quarter of 2024 May 07, 2024 From Quanterix Corporation Via Business Wire Quanterix To Report First Quarter 2024 Financial Results April 29, 2024 From Quanterix Corporation Via Business Wire Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure March 21, 2024 From Quanterix Via Business Wire Earnings Preview: Quanterix February 28, 2024 Via Benzinga Earnings Scheduled For February 27, 2024 February 27, 2024 Via Benzinga A Preview Of Quanterix's Earnings February 26, 2024 Via Benzinga Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease March 04, 2024 From Quanterix Corporation Via Business Wire Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023 February 29, 2024 From Quanterix Corporation Via Business Wire Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance February 26, 2024 From Quanterix Corporation Via Business Wire Earnings Outlook For Quanterix February 23, 2024 Via Benzinga Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease February 26, 2024 From Quanterix Corporation Via Business Wire Earnings Scheduled For February 26, 2024 February 26, 2024 Via Benzinga Quanterix to Present at Cowen’s 44th Annual Health Care Conference February 23, 2024 From Quanterix Corporation Via Business Wire Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call February 16, 2024 From Quanterix Corporation Via Business Wire Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference December 12, 2023 From Quanterix Corporation Via Business Wire Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 13, 2023 From Quanterix Corporation Via Business Wire Sotera Health Appoints Karen Flynn to Board of Directors November 13, 2023 From Sotera Health Services, LLC Via GlobeNewswire Quanterix Releases Operating Results for Third Quarter 2023 November 06, 2023 From Quanterix Corporation Via Business Wire 7 Stocks to Buy if You Anticipate a Hot November November 06, 2023 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.